https://synapse.patsnap.com/drug/82f5a6b6154d47669534f9c8c1c5e34e
PI3Kδ inhibitors(CHIESI Farmaceutici SpA) - Drug Targets, Indications, Patents - Synapse
chiesi farmaceuticiinhibitorsspadrugtargets
https://www.chiesi.com/en/media-hub/news/us-fda-approves-trimbow-for-maintenance-treatment-of-asthma-in-adults.html
U.S. FDA approves TRIMBOW for asthma maintenance | Chiesi Farmaceutici S.p.A.
The U.S. FDA has approved Chiesi's single-inhaler triple therapy (BDP/FF/G) for maintenance treatment of asthma in adults, backed by two Phase 3 trials.
u schiesi farmaceuticifdaapprovestrimbow
https://www.chiesi.com/it/privacy.html
Privacy | Chiesi Farmaceutici S.p.A.
s p achiesi farmaceuticiprivacy